20 May 2022 - - To support the Greater Boston biotech ecosystem, US-based lab instrument maker Thermo Fisher Scientific (NYSE: TMO) is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumab...
20 May 2022 - - The US FDA has approved of a supplemental New Drug Application for Annovera, US-based TherapeuticsMD, Inc. (NASDAQ: TXMD) said.


The sNDA included minor revisions to Annovera's in vitro release testing spe...
20 May 2022 - - US-based life sciences and materials science company Schrödinger, Inc. (NASDAQ: SDGR), whose physics-based software platform is used for therapeutics and materials discovery, has appointed Arun Oberoi to its board of directors, t...
20 May 2022 - - US-based clinical-stage company Nimbus Therapeutics has presented new data from multiple Phase 1 clinical studies of its investigational oral allosteric tyrosine kinase 2 inhibitor, NDI-034858, in both healthy volunteers and patients ...
20 May 2022 - - US-based clinical stage gene therapy company Myrtelle Inc has entered into a worldwide exclusive licensing agreement with Rescue Hearing Inc. to develop a novel gene therapy for DFNB8 genetic hearing loss, the company said.